UNSPSC 85612925: Supplement pancreatic duct with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement pancreatic duct with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FUD0KZ

UNSPSC 85612925 Supplement pancreatic duct with nonautologous tissue substitute, open approach is a Commodity code that nominally describes surgical implant procedures, yet recent state and local procurement activity under this code shows no alignment with that scope. The six recent opportunities posted under this code span occupational medical surveillance, disability medical evaluations, pharmacy benefit management, temporary health professional staffing, surgical benefit carve-out programs, and youth detention healthcare services — none involving pancreatic duct supplementation or tissue substitutes. The mismatch reflects a classification error rather than substantive procurement in this category's defined scope.

The issuing bodies include a state transportation department (Washington State Department of Transportation), two city retirement systems (City of Phoenix), a municipal government (City of Long Beach), county health systems and procurement offices (Collier County, Harris County, Santa Clara County), and a county juvenile probation department. Geographic activity spans Washington, Arizona, California, Texas, and Florida. The Washington State Department of Transportation posted an RFP for occupational medical surveillance services across 14 ferry terminal and vessel locations (proposals due October 9, 2026); the City of Phoenix Retirement Office posted an RFP for disability medical record summary and independent medical examination coordination for public safety pension determinations (proposals due October 16, 2026); and Collier County posted an RFP for pharmacy benefit management services covering approximately 2,400 enrolled employees with historical annual spending of $8.7 million (proposals due April 9, 2026). This code shows little relevant recent activity and appears to be applied incorrectly by state and local procurement offices.